About Codexis, Inc.
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Codexis, Inc. (CDXS) Stock Score & Signals
Codexis, Inc. (CDXS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 44 out of 100.
2BB score and signals
Codexis, Inc.’s current 2BB score is 44 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 46 | Moderate |
| Momentum | 60 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 93 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| CEO | John Nicols |
| Headquarters | Redwood City, California, United States |
| Founded | 2002 |
| Employees | 146 |
| 52-week range | $0.96 – $2.98 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-09 | — | -0.0612 | — | $25.51M |
| 2026-10-29 | — | -0.0976 | — | $19.09M |
| 2026-08-11 | -0.13 | -0.1408 | $14.92M | $14.64M |
| 2026-05-07 | -0.1 | -0.1394 | $15.25M | $14.82M |